Reported Consolidated quarterly numbers for Suven Life Sciences are:
Net Sales at Rs 1.61 crore in December 2024 down 34.31% from Rs. 2.45 crore in December 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 39.12 crore in December 2024 up 6.34% from Rs. 41.76 crore in December 2023.
EBITDA stands negative at Rs. 37.58 crore in December 2024 up 6.35% from Rs. 40.13 crore in December 2023.
Suven Life Sci shares closed at 116.02 on January 24, 2025 (NSE) and has given -17.46% returns over the last 6 months and 10.76% over the last 12 months.
Story continues below Advertisement
| Suven Life Sciences | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'24 | Sep'24 | Sep'23 | | Net Sales/Income from operations | 1.61 | 2.57 | 3.06 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1.61 | 2.57 | 3.06 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.87 | 5.20 | 4.45 | | Depreciation | 1.53 | 1.46 | 1.73 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | 34.13 | 47.58 | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.82 | 1.99 | 22.12 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -40.74 | -53.66 | -25.24 | | Other Income | 1.63 | 4.04 | 5.14 | | P/L Before Int., Excpt. Items & Tax | -39.11 | -49.63 | -20.09 | | Interest | 0.01 | 0.02 | 0.04 | | P/L Before Exceptional Items & Tax | -39.12 | -49.64 | -20.14 | | Exceptional Items | -- | -- | 7.46 | | P/L Before Tax | -39.12 | -49.64 | -12.68 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -39.12 | -49.64 | -12.68 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -39.12 | -49.64 | -12.68 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -39.12 | -49.64 | -12.68 | | Equity Share Capital | 21.81 | 21.81 | 21.81 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.79 | -2.27 | -0.58 | | Diluted EPS | -1.79 | -2.27 | -0.58 | | EPS After Extra Ordinary | | Basic EPS | -1.79 | -2.27 | -0.58 | | Diluted EPS | -1.79 | -2.27 | -0.58 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
